Aurora Cannabis Losses Deepen Despite Revenue Gains

A sharp rise in operational expenses pushed Aurora Cannabis into a deeper hole this quarter, as the company reported a net loss of 27.6 million Canadian dollars. While revenue managed to climb above analyst expectations, the bottom line suffered significantly compared to the 12.1 million loss recorded during the same period last year.

June 11, 2026, 04:55 PM 0 0

The company attributed the financial slip primarily to a shift in other expenses, which totaled 1.7 million Canadian dollars against a year-ago income of 11.9 million. On an adjusted basis—excluding one-off costs—earnings dropped to 5.6 million Canadian dollars from 15.3 million. Total revenue reached 84.8 million Canadian dollars, outpacing the 75.7 million analysts had anticipated.

Growth was driven by a 14% expansion in the global medical cannabis division and increased wholesale bulk sales. These gains were partially offset by a slump in consumer cannabis, which saw revenue shrink by more than half compared to the previous year.

When reusing this material a link to Money Talk is required.